NCCN ALL Response Criteria for Blood and Bone Marrow Progressive Disease

**Semantic type:** Intellectual Product

**Definition:** Increase of at least 25 percent in the absolute number of circulating or bone marrow blasts or development of extramedullary disease. (Adapted from NCCN Guidelines, Version 1.2020, February 20, 2020)